Literature DB >> 19276801

The value of early detection of type 2 diabetes.

Stephen Colagiuri1, Daniel Davies.   

Abstract

PURPOSE OF REVIEW: To examine the value of early detection of type 2 diabetes from the perspective of potential benefits and harms to the individual, and from the perspective of the health system. RECENT
FINDINGS: Early detection of type 2 diabetes can be justified because diabetes is an important health problem, has a relatively long asymptomatic phase, interventions are available that have a proven beneficial effect on clinically meaningful outcomes and screening procedures are safe, acceptable and have adequate sensitivity and specificity. However, it remains controversial because of a lack of an established evidence base that detection earlier in the natural history of diabetes is indeed beneficial to individuals.
SUMMARY: Although there are many reasons why the earlier detection of diabetes could be beneficial, the magnitude of any potential benefit of early detection and treatment has yet to be quantitated in a randomized controlled trial and this information will be available in 2010 when the Anglo-Danish-Dutch Study of Intensive Treatment and Complication reports its findings.

Entities:  

Mesh:

Year:  2009        PMID: 19276801     DOI: 10.1097/MED.0b013e328329302f

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  11 in total

1.  Diabetes screening among immigrants: a population-based urban cohort study.

Authors:  Maria I Creatore; Gillian L Booth; Douglas G Manuel; Rahim Moineddin; Richard H Glazier
Journal:  Diabetes Care       Date:  2012-02-22       Impact factor: 19.112

2.  Social status and participation in health checks in men and women in Germany: results from the German Health Update (GEDA), 2009 and 2010.

Authors:  Jens Hoebel; Matthias Richter; Thomas Lampert
Journal:  Dtsch Arztebl Int       Date:  2013-10-11       Impact factor: 5.594

3.  Statins are associated with new onset type 2 diabetes mellitus (T2DM) in Medicare patients ≥65 years.

Authors:  Srikanth Tangelloju; Bert B Little; Robert J Esterhay; Guy Brock; Scott LaJoie
Journal:  Diabetes Metab Res Rev       Date:  2020-04-03       Impact factor: 8.128

4.  Adapting existing diabetes risk scores for an Asian population: a risk score for detecting undiagnosed diabetes in the Mongolian population.

Authors:  Otgontuya Dugee; Oyunbileg Janchiv; Pekka Jousilahti; Ariuntuya Sakhiya; Enkhtuya Palam; J Pekka Nuorti; Markku Peltonen
Journal:  BMC Public Health       Date:  2015-09-22       Impact factor: 3.295

5.  TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy.

Authors:  C Costagliola; V Romano; M De Tollis; F Aceto; R dell'Omo; M R Romano; C Pedicino; F Semeraro
Journal:  Mediators Inflamm       Date:  2013-10-23       Impact factor: 4.711

Review 6.  Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk.

Authors:  Antonino Di Pino; Francesca Urbano; Salvatore Piro; Francesco Purrello; Agata Maria Rabuazzo
Journal:  World J Diabetes       Date:  2016-10-15

7.  Google Trends can improve surveillance of Type 2 diabetes.

Authors:  Nataliya Tkachenko; Sarunkorn Chotvijit; Neha Gupta; Emma Bradley; Charlotte Gilks; Weisi Guo; Henry Crosby; Eliot Shore; Malkiat Thiarai; Rob Procter; Stephen Jarvis
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

8.  Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study.

Authors:  Bernd Kowall; Wolfgang Rathmann; Andreas Stang; Brenda Bongaerts; Oliver Kuss; Christian Herder; Michael Roden; Anne Quante; Rolf Holle; Cornelia Huth; Annette Peters; Christa Meisinger
Journal:  PLoS One       Date:  2017-01-31       Impact factor: 3.240

Review 9.  High rates of undiagnosed diabetes mellitus among patients with active tuberculosis in Addis Ababa, Ethiopia.

Authors:  Degu Jerene; Chaltu Muleta; Abdurezak Ahmed; Getahun Tarekegn; Tewodros Haile; Ahmed Bedru; Agnes Gebhard; Fraser Wares
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-02-23

Review 10.  Extracellular vesicles-incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications.

Authors:  Nicoleta Alexandru; Anastasia Procopciuc; Alexandra Vîlcu; Ioana Karla Comariţa; Elisabeta Bӑdilӑ; Adriana Georgescu
Journal:  Rev Endocr Metab Disord       Date:  2021-06-18       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.